Cellectis S.A.
CLLS
$3.59
$0.092.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.40M | 35.17M | 16.73M | 10.66M | 12.72M |
| Total Other Revenue | 1.81M | 1.99M | 1.47M | 1.37M | 2.45M |
| Total Revenue | 12.21M | 37.16M | 18.19M | 12.03M | 15.17M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 12.21M | 37.16M | 18.19M | 12.03M | 15.17M |
| SG&A Expenses | 4.80M | 5.21M | 5.08M | 4.70M | 4.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 320.00K | -154.00K | -378.00K | -426.00K | 47.00K |
| Total Operating Expenses | 29.56M | 29.12M | 27.78M | 26.21M | 25.85M |
| Operating Income | -17.35M | 8.04M | -9.59M | -14.18M | -10.68M |
| Income Before Tax | -26.74M | 589.00K | -23.74M | -18.13M | 6.44M |
| Income Tax Expenses | -423.00K | -- | -- | -- | 514.00K |
| Earnings from Continuing Operations | -26.32M | 589.00K | -23.74M | -18.13M | 5.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.32M | 589.00K | -23.74M | -18.13M | 5.92M |
| EBIT | -17.35M | 8.04M | -9.59M | -14.18M | -10.68M |
| EBITDA | -15.33M | 11.17M | -6.46M | -11.13M | -7.45M |
| EPS Basic | -0.26 | 0.01 | -0.24 | -0.18 | 0.06 |
| Normalized Basic EPS | -0.17 | 0.00 | -0.15 | -0.11 | 0.13 |
| EPS Diluted | -0.26 | 0.01 | -0.24 | -0.18 | 0.06 |
| Normalized Diluted EPS | -0.17 | 0.00 | -0.15 | -0.11 | 0.13 |
| Average Basic Shares Outstanding | 100.33M | 100.33M | 98.90M | 100.16M | 100.09M |
| Average Diluted Shares Outstanding | 100.33M | 101.71M | 98.90M | 100.16M | 100.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |